Skip to main content

Advances in Cancer Medicine: Our Momentum of Discovery

Featured Content |Content Library

Updated Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Clinical Trials Video

Updated Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Clinical Trials

Dana-Farber Cancer Institute Establishes the David Liposarcoma Research Initiative News

Dana-Farber Cancer Institute Establishes the David Liposarcoma Research Initiative

Study Pairs Two Forms of Immunotherapy in Patients with Advanced Kidney Cancer News

Study Pairs Two Forms of Immunotherapy in Patients with Advanced Kidney Cancer

Phenotype, Specificity and Avidity of Antitumour CD8+ T Cells in Melanoma Video

Phenotype, Specificity and Avidity of Antitumour CD8+ T Cells in Melanoma

Antibiotic Novobiocin Found to Kill Tumor Cells with DNA-Repair Glitch News

Antibiotic Novobiocin Found to Kill Tumor Cells with DNA-Repair Glitch

Cancer Screenings Rebounded in Late 2020 After COVID-related Decline, but Racial and Economic Disparities Remain for Some Tests News

Cancer Screenings Rebounded in Late 2020 After COVID-related Decline, but Racial and Economic Disparities Remain for Some Tests

Education/CME


Updates

Receive Dana-Farber's e-newsletter, Momentum, to learn of advances in cancer research and care, current clinical trials, and upcoming CME programs.

 
Season two of Dana-Farber's podcast, Unraveled, is now available. Listen Now